Artemisinin-treatment in pre-symptomatic APP-PS1 mice increases gephyrin phosphorylation at Ser270: a modification regulating postsynaptic GABAAR density
Open Access
- 20 April 2021
- journal article
- research article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 403 (1) , 73-87
Abstract
Artemisinins, a group of plant-derived sesquiterpene lactones, are efficient antimalarial agents. They also share anti-inflammatory and anti-viral activities and were considered for treatment of neurodegenerative disorders like Alzheimer’s disease (AD). Additionally, artemisinins bind to gephyrin, the multifunctional scaffold of GABAergic synapses, and modulate inhibitory neurotransmission in vitro. We previously reported an increased expression of gephyrin and GABAA receptors in early pre-symptomatic stages of an AD mouse model (APP-PS1) and in parallel enhanced CDK5-dependent phosphorylation of gephyrin at S270. Here, we studied the effects of artemisinin on gephyrin in the brain of young APP-PS1 mice. We detected an additional increase of gephyrin protein level, elevated gephyrin phosphorylation at Ser270, and an increased amount of GABAAR-γ2 subunits after artemisinin-treatment. Interestingly, the CDK5 activator p35 was also upregulated. Moreover, we demonstrate decreased density of postsynaptic gephyrin and GABAAR-γ2 immunoreactivities in cultured hippocampal neurons expressing gephyrin with alanine mutations at two CDK5 phosphorylation sites. In addition, the activity-dependent modulation of synaptic protein density was abolished in neurons expressing gephyrin lacking one or both of these phosphorylation sites. Thus, our results reveal that artemisinin modulates expression as well as phosphorylation of gephyrin at sites that might have important impact on GABAergic synapses in AD.Keywords
Funding Information
- Romanian Ministry of Research and Innovation (PN-III-P4-ID-PCE-2016-0052)
- Alzheimer Forschung Initiative e.V. (17024)
This publication has 52 references indexed in Scilit:
- Quantitative Nanoscopy of Inhibitory Synapses: Counting Gephyrin Molecules and Receptor Binding SitesNeuron, 2013
- Antimalarial Drug Artemisinin Extenuates Amyloidogenesis and Neuroinflammation in APPswe/PS1dE9 Transgenic Mice via Inhibition of Nuclear Factor‐κB and NLRP3 Inflammasome ActivationCNS Neuroscience & Therapeutics, 2013
- Phosphorylation of Gephyrin in Hippocampal Neurons by Cyclin-dependent Kinase CDK5 at Ser-270 Is Dependent on CollybistinJournal of Biological Chemistry, 2012
- Splice-specific Glycine Receptor Binding, Folding, and Phosphorylation of the Scaffolding Protein GephyrinJournal of Biological Chemistry, 2012
- Gephyrin-mediated γ-Aminobutyric Acid Type A and Glycine Receptor Clustering Relies on a Common Binding SiteJournal of Biological Chemistry, 2011
- Regulation of GABAergic synapse formation and plasticity by GSK3β-dependent phosphorylation of gephyrinProceedings of the National Academy of Sciences, 2010
- CDK5 Serves as a Major Control Point in Neurotransmitter ReleaseNeuron, 2010
- Synaptic Plasticity in the Hippocampus of a APP/PS1 Mouse Model of Alzheimer's Disease Is Impaired in Old but Not Young MicePLOS ONE, 2010
- Post‐phosphorylation prolyl isomerisation of gephyrin represents a mechanism to modulate glycine receptors functionThe EMBO Journal, 2007
- Aβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathologyEMBO Reports, 2006